GSA Capital Partners’s GSK GSK Stock Holding History

GSA Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,899	Closed	-$380K	–	1562
2021 Q4	$380K	Buy	+6,899	New	+$359K	0.05%	776
2021 Q2	–	Sell	-7,034	Closed	-$314K	–	1423
2021 Q1	$314K	Buy	+7,034	New	+$319K	0.05%	620
2020 Q1	–	Sell	-5,920	Closed	-$348K	–	1245
2019 Q4	$348K	Buy	+5,920	New	+$329K	0.04%	906
2016 Q1	–	Sell	-4,334	Closed	-$219K	–	1768
2015 Q4	$219K	Buy	+4,334	New	+$221K	0.01%	1612
2015 Q2	–	Sell	-6,126	Closed	-$353K	–	2034
2015 Q1	$353K	Buy	+6,126	New	+$351K	0.01%	1613
2014 Q4	–	Sell	-5,134	Closed	-$295K	–	1775
2014 Q3	$295K	Buy	+5,134	New	+$315K	0.02%	1274
2014 Q2	–	Sell	-6,841	Closed	-$457K	–	1868
2014 Q1	$457K	Buy	+6,841	New	+$462K	0.03%	840
2013 Q4	–	Sell	-3,619	Closed	-$227K	–	1681
2013 Q3	$227K	Sell	3,619 -2,555	-41%	-$164K	0.02%	1320
2013 Q2	$386K	Buy	+6,174	New	+$392K	0.05%	717

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

GSA Capital Partners's GSK Position: Q1 2022 in Review

GSA Capital Partners sold out of GSK (GSK) in Q1 2022, closing a stake of 6,899 shares — an estimated $380K sold.

GSA Capital Partners first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $457K in Q1 2014. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

GSA Capital Partners reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
GSA Capital Partners sold 6,899 GSK shares in Q1 2022, an estimated $380K.
GSA Capital Partners first reported a position in GSK in Q2 2013 and held it in 9 quarters.
GSA Capital Partners's GSK position peaked at $457K in Q1 2014.
929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.